severe COVID-19 infection and pneumonia

Communiqué de presse

17 juillet 2020 ABC294640), Gilead Raday, Israël, opaganib (Yeliva®, ...

Clinical Trial Application approved in Russia for the Phase 2/3 study with opaganib in severe COVID-19 patients following recent approval […]